EP 0573565 B1 20000719 - OPIATE RECEPTOR ANTAGONIST MODULATES HYPERKINETIC MOVEMENT DISORDER
Title (en)
OPIATE RECEPTOR ANTAGONIST MODULATES HYPERKINETIC MOVEMENT DISORDER
Title (de)
HYPERKINETISCHE BEWEGUNGSSTÖRUNG MODULIERENDER OPIATREZEPTOR-ANTAGONIST
Title (fr)
ANTAGONISTE DE RECEPTEUR OPIACE MODULANT LES MOUVEMENTS HYPERCINETIQUES ANORMAUX
Publication
Application
Priority
- US 9201418 W 19920225
- US 66054391 A 19910225
Abstract (en)
[origin: US6153620A] A method for modulating onset of tardive dyskinesia in a subject includes the step of administering to the subject an opiate receptor antagonist concomitantly with the neuroleptic. Also, a method for modulating a genetic or idiopathic or psychogenic hyperkinetic movement disorder, such as that characteristic of Huntington's Disease, includes the step of administering to the subject an opiate receptor antagonist.
IPC 1-7
IPC 8 full level
A61K 31/445 (2006.01); A61K 31/00 (2006.01); A61K 31/485 (2006.01); A61K 45/06 (2006.01); A61P 25/00 (2006.01); A61P 25/18 (2006.01); A61P 25/30 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP US)
A61K 31/485 (2013.01 - EP US); A61P 25/00 (2018.01 - EP); A61P 25/18 (2018.01 - EP); A61P 25/30 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
C-Set (source: EP US)
Designated contracting state (EPC)
AT DE ES FR GB IT
DOCDB simple family (publication)
WO 9214364 A1 19920903; AT E194753 T1 20000815; AU 1456392 A 19920915; AU 658401 B2 19950413; CA 2104229 A1 19920826; CA 2104229 C 19970415; DE 69231274 D1 20000824; DE 69231274 T2 20001130; EP 0573565 A1 19931215; EP 0573565 A4 19940318; EP 0573565 B1 20000719; ES 2148174 T3 20001016; JP H06505747 A 19940630; US 6153620 A 20001128
DOCDB simple family (application)
US 9201418 W 19920225; AT 92907704 T 19920225; AU 1456392 A 19920225; CA 2104229 A 19920225; DE 69231274 T 19920225; EP 92907704 A 19920225; ES 92907704 T 19920225; JP 50735792 A 19920225; US 669193 A 19930121